Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Testosterone × 1 year × Clear all

Phase

Phase 2 3 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Hypogonadism 1

Interventions

Carboplatin 184 pembrolizumab 177 Cisplatin 173 Paclitaxel 153 Gemcitabine 123 Docetaxel 104 Capecitabine 97 Cyclophosphamide 89 Pemetrexed 87 Dexamethasone 86 Doxorubicin 82 Specimen Handling 80 Oxaliplatin 80 Magnetic Resonance Spectroscopy 78 Radiotherapy 76 Fluorouracil 71 Bevacizumab 69 Nivolumab 66 Rituximab 63 Leucovorin 61 Vincristine 59 Lenalidomide 57 durvalumab 55 atezolizumab 52 Radiation 51 Prednisone 51 Etoposide 50 Irinotecan 48 Trastuzumab 47 Drug Therapy 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04833426 2025-05-02

ENFORCE

Canisius-Wilhelmina Hospital

Phase 3 Recruiting

Hypogonadism, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡